Physician profile
Caitlyn Mitchell
NPI 1518221142
$2,521.06
in general payments reported to CMS, 2019-2025
24 companies · $818 in 2025
The $818 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $391 · 2020: $117 · 2021: $299 · 2022: $278 · 2023: $169 · 2024: $449 · 2025: $818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,436.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $456.88 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $274.11 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $267.73 | 2020-2023 | |
| Alcon Vision LLC | $236.89 | 2019-2025 | Rocklatan, Eysuvis, Tryptyr |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $196.49 | 2019-2021 | |
| Oyster Point Pharma, INC. | $152.24 | 2023-2025 | Tyrvaya, Ryzumvi |
| Eyevance Pharmaceuticals LLC | $139.75 | 2019-2022 | |
| Dompe US, INC. | $110.41 | 2019-2025 | Oxervate |
| Kala Pharmaceuticals, INC. | $106.83 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $101.81 | 2024-2025 | Eylea Hd, Eylea |
| Abbvie INC. | $80.38 | 2022-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $53.10 | 2021-2025 | Tecnis Iol |
| Bausch & Lomb Americas INC. | $53.04 | 2024-2025 | Xiidra, Miebo, Vyzulta |
| Sight Sciences, INC. | $46.96 | 2022 | |
| Harrow Eye, LLC | $43.64 | 2024 | Vevye |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $36.48 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $33.55 | 2021 | |
| Amgen INC. | $25.38 | 2025 | Tepezza |
| Genentech USA, INC. | $25.07 | 2023 | Vabysmo |
| Thea Pharma INC. | $21.20 | 2025 | Iyuzeh |
| Biotissue Holdings INC. | $18.08 | 2021 | |
| Shire North American Group INC | $17.34 | 2019 | |
| Optos, INC. | $11.96 | 2019 | |
| Rayner Intraocular Lenses Limited | $11.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlyn Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.